ShareHope Medicine Co., Ltd. - Laporan Laba Rugi (TTM)

ShareHope Medicine Co., Ltd.
TW ˙ TPEX
NT$ 30.05 0.00 (0.00%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi ShareHope Medicine Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 3,783 4,099 4,158 4,145 3,906 3,850 3,989 4,162 4,278 4,137 3,993 3,818 3,732 3,873 3,950 4,100 4,281 4,326 4,405 4,386
Change (%) 8.34 1.45 -0.33 -5.77 -1.42 3.60 4.35 2.78 -3.28 -3.49 -4.37 -2.26 3.78 1.97 3.81 4.41 1.05 1.83 -0.43
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,758 2,919 2,951 3,023 3,010 3,016 3,047 3,135 3,144 3,153 3,130 3,054 3,115 3,147 3,219 3,361 3,514 3,611 3,688 3,691
Change (%) 5.84 1.09 2.45 -0.43 0.19 1.02 2.90 0.26 0.31 -0.72 -2.45 2.02 1.01 2.29 4.39 4.57 2.77 2.11 0.08
% of Revenue 72.90 71.21 70.96 72.95 77.08 78.34 76.39 75.33 73.49 76.22 78.40 79.98 83.48 81.25 81.50 81.96 82.08 83.49 83.72 84.15
Gross Operating Profit 1,025 1,180 1,207 1,121 895 834 942 1,027 1,134 984 863 765 617 726 731 740 767 714 717 695
Change (%) 15.09 2.33 -7.13 -20.16 -6.85 12.93 9.03 10.44 -13.23 -12.33 -11.37 -19.33 17.78 0.58 1.25 3.68 -6.85 0.40 -3.07
% of Revenue 27.10 28.79 29.04 27.05 22.92 21.66 23.61 24.67 26.51 23.78 21.60 20.02 16.52 18.75 18.50 18.04 17.92 16.51 16.28 15.85
SG&A 621 710 725 730 723 649 672 695 748 716 700 687 647 700 704 728 719 738 733 709
Change (%) 14.39 2.20 0.66 -0.99 -10.24 3.63 3.38 7.64 -4.31 -2.30 -1.75 -5.90 8.28 0.52 3.42 -1.18 2.66 -0.79 -3.29
% of Revenue 16.40 17.32 17.45 17.62 18.51 16.85 16.86 16.70 17.49 17.31 17.52 18.00 17.33 18.08 17.82 17.75 16.80 17.07 16.63 16.16
R&D 4 7 13 16 15 16 13 12 12 12 12 12 12 10
Change (%) 86.52 92.07 26.70 -6.43 1.32 -13.93 -8.04 -3.81 3.30 -3.12 -0.23 -0.69 -15.87
% of Revenue 0.09 0.16 0.30 0.40 0.38 0.41 0.36 0.32 0.30 0.30 0.28 0.27 0.27 0.23
OpEx 3,335 3,585 3,634 3,709 3,685 3,596 3,646 3,755 3,817 3,808 3,767 3,676 3,693 3,779 3,853 4,020 4,166 4,283 4,354 4,349
Change (%) 7.50 1.36 2.05 -0.63 -2.42 1.41 2.98 1.64 -0.24 -1.08 -2.42 0.47 2.32 1.97 4.34 3.63 2.81 1.66 -0.11
% of Revenue 88.16 87.47 87.39 89.48 94.35 93.40 91.42 90.22 89.23 92.04 94.34 96.26 98.95 97.56 97.55 98.05 97.32 99.01 98.86 99.17
Operating Income 448 514 524 436 221 254 342 407 461 329 226 143 39 95 97 80 115 43 50 36
Change (%) 14.65 2.05 -16.83 -49.42 15.30 34.58 18.90 13.22 -28.50 -31.33 -36.90 -72.53 141.50 2.11 -17.37 43.44 -62.82 18.30 -27.78
% of Revenue 11.84 12.53 12.61 10.52 5.65 6.60 8.58 9.78 10.77 7.96 5.66 3.74 1.05 2.44 2.45 1.95 2.68 0.99 1.14 0.83
Interest Expense -15 -15 -15 -16 -18 -20 -22 -25 -31 -38 -45 -51 -53 -54 -55 -55 -55 -57 -56 -54
Change (%) -1.68 0.65 7.58 15.30 10.87 8.78 14.34 24.98 22.02 18.84 13.54 3.06 1.19 2.70 -0.20 0.52 3.84 -3.01 -2.71
% of Revenue -0.39 -0.35 -0.35 -0.38 -0.46 -0.52 -0.55 -0.60 -0.73 -0.92 -1.13 -1.35 -1.42 -1.38 -1.39 -1.34 -1.29 -1.33 -1.26 -1.23
Net Income 202 248 339 302 209 233 296 360 433 294 215 145 41 125 112 150 157 200 207 163
Change (%) 22.74 37.04 -10.96 -30.90 11.40 27.28 21.61 20.16 -32.07 -26.94 -32.53 -72.05 207.51 -10.34 34.36 4.71 27.34 3.25 -20.94
% of Revenue 5.33 6.04 8.16 7.29 5.35 6.04 7.42 8.65 10.12 7.11 5.38 3.80 1.09 3.22 2.83 3.66 3.67 4.63 4.69 3.72

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista